aducanumab
Jump to navigation
Jump to search
English[edit]
Etymology[edit]
-n- (“neural”) + -umab (“human monoclonal antibody”).
(This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.)
Noun[edit]
aducanumab (uncountable)
- (pharmacology) A human monoclonal antibody and drug candidate designed for treatment of Alzheimer's disease.
- 2015 July 19, The New York Times, “Greece’s Debt Payments, Apple Earnings and Credit Suisse Results”, in New York Times[1]:
- Biogen’s drug, aducanumab, slowed the decline in cognition in an early-stage trial.
Spanish[edit]
Noun[edit]
aducanumab m (plural aducanumabs)